DAVITA INC. — Director's Dealing 2021

Jun 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Miromatrix Medical Inc. (MIRO)
CIK: 0001527096
Period of Report: 2021-06-28

Reporting Person: Cheshire MD Holdings, LLC (10% Owner)
Reporting Person: DAVITA INC. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-28	Common Stock	C	933334	—	Acquired	933334	Direct
2021-06-28	Common Stock	C	1046757	—	Acquired	1980091	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-28	Series B-2 Preferred Stock	$	C	933334	Disposed		Common Stock (933334.0)	Direct
2021-06-28	Series C Preferred Stock	$	C	1004887	Disposed		Common Stock (1046757.0)	Direct

Footnotes

F1: Each share of Series B-2 Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's Initial Public Offering ("IPO").

F2: As a result of DaVita Inc.'s ownership interest in Cheshire MD Holdings, LLC, DaVita Inc. may be deemed to have an indirect pecuniary interest in the shares held directly by Cheshire MD Holdings, LLC.

F3: Each share of Series C Preferred Stock had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's IPO at a rate determined by dividing $7.50 by $7.20.